Carregant...
DEFUSE 3 Non-DAWN Patients: A Closer Look at Late Window Thrombectomy Selection
BACKGROUND AND PURPOSE: DAWN and DEFUSE 3 established thrombectomy for patients with emergent large vessel occlusions (ELVO) presenting 6–24 hours after symptom onset. Given the greater inclusivity of DEFUSE 3 we evaluated the effect of thrombectomy in DEFUSE 3 patients who would have been excluded...
Guardat en:
| Publicat a: | Stroke |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6768068/ https://ncbi.nlm.nih.gov/pubmed/30727856 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.118.023310 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|